Last updated on October 2011

New Alzheimer’s Disease Research

Brief description of study

New Alzheimer’s Disease Research

Detailed Study Description

NeuroTrials Research is conducting a 20-month, placebo-controlled research study evaluating an investigational drug for Alzheimer’s Disease. Study-related exams and study drug are provided at no cost. Qualified participants and caregivers will be compensated for time and travel.

Patient Inclusion Criteria:

  • Age 50-89
  • Diagnosis of probable Alzheimer’s Disease
  • Must have a caregiver capable of attending all study visits.
  • In general good health

Patient Exclusion Criteria:

  • History of seizures, strokes or brain abnormalities

Clinical Study Identifier: TX135500

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.